Celldex Therapeutics Shares Down 31.0% Since SmarTrend's Sell Call (CLDX)
January 27, 2016 at 15:15 PM EST
SmarTrend identified a Downtrend for Celldex Therapeutics (NASDAQ:CLDX) on December 14th, 2015 at $14.17. In approximately 1 month, Celldex Therapeutics has returned 31.03% as of today's recent price of...